EP3204424
COMBINATION THERAPY OF C-C CHEMOKINE RECEPTOR-9 (CCR9) INHIBITORS AND ANTI-ALPHA4BETA7 INTEGRIN BLOCKING ANTIBODIES FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.10.2015EP published:
29.11.2023EP application number:
15848916.1
EPO information:
European Patent Register
Max expiry date:
4.10.2035
Title in English:
COMBINATION THERAPY OF C-C CHEMOKINE RECEPTOR-9 (CCR9) INHIBITORS AND ANTI-ALPHA4BETA7 INTEGRIN BLOCKING ANTIBODIES FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASELanguage of the patent:
English
Timeline
Today
5.10.2015EP application
29.11.2023EP Publication
Owner
Name:
ChemoCentryx, Inc.Address:
One Amgen Center Drive, Thousand Oaks, CA 91320, US
Inventor
Name:
EBSWORTH, KarenAddress:
San Francisco, California 94111, US
Name:
WANG, YuAddress:
Palo Alto, California 94306, US
Name:
ZENG, YibinAddress:
Foster City, California 94404, US
Name:
ZHANG, PenglieAddress:
Foster City, California 94404, US
Name:
TAN, JoanneAddress:
San Francisco, California 94110, US
Priority
Number:
201462060454 PDate:
6.10.2014Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61K 31/517, A61K 47/14, A61P 1/00, A61K 31/4412